Close
ACHEMA MIDDLE EAST 2026

Global Biopharma Market to Hit $566B by 2032

Global Biopharma Market Forecasts $566B By 2032 opposing Challenges With a compound annual growth rate of almost 8%, from $263 billion in 2022 to $566...

CDMO Growth and Biotechnology Outsourcing Trends

Since many contract manufacturing companies (CMOs) are the only ones able to produce the vast quantities of medications and treatments required, outsourcing has grown...

Lilly to Build $6.5B API Manufacturing Facility in Houston

Eli Lilly and Company has unveiled plans for a $6.5 billion manufacturing facility in Generation Park, Houston, Texas. The project, described as a next-generation...

Amgen to Expand U.S. Manufacturing with $650M Investment

Amgen has announced a $650 million expansion of its U.S. manufacturing facilities, a development that will create almost 750 new positions. The expansion will...

AbbVie Launches New API Manufacturing Facility in Illinois

AbbVie has started construction of a new active pharmaceutical ingredient (API) manufacturing facility in North Chicago, Illinois, a critical milestone in its strategy to...

US FDA Launches Fast-Track Review Scheme for Generic Drugs

The FDA has introduced a pilot fast-track review programme aimed at accelerating reviews for generic medicines tested and manufactured within the United States, marking...

Roche’s Genentech Launches New Manufacturing Facility in USA

Genentech, part of the Roche Group, has broken ground on its latest US manufacturing facility in Holly Springs, North Carolina. The development represents the...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...